Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
NCT00021983
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Leukemia
Interventions
BIOLOGICAL:
BL22 immunotoxin
Sponsor
National Cancer Institute (NCI)